Jing Bian, Junfeng Xu, Xiuyun Li, Xianhui Ding, Yapeng Guo, Ke Yang, Xianjun Huang, Shoucai Zhao, Zhiming Zhou, Zibao Li
{"title":"The C-Reactive Protein–Triglyceride–Glucose Index and Functional Outcomes in Acute Ischemic Stroke Patients Following Endovascular Thrombectomy","authors":"Jing Bian, Junfeng Xu, Xiuyun Li, Xianhui Ding, Yapeng Guo, Ke Yang, Xianjun Huang, Shoucai Zhao, Zhiming Zhou, Zibao Li","doi":"10.1002/brb3.71770","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and Purpose</h3>\n \n <p>The C-reactive protein–triglyceride–glucose index (CTI), capturing insulin resistance (IR) and systemic inflammation, is related to stroke prognosis in general, but has not yet been studied with respect to functional outcomes after endovascular thrombectomy (EVT).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A retrospective analysis was carried out on individuals with acute ischemic stroke (AIS) experiencing EVT (September 2018–December 2024). CTI is measured as: 0.412 × Ln (C-reactive protein) (mg/L) + Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)]/2. The endpoint was unfavorable functional outcomes, characterized by a modified Rankin Scale (mRS) score of 3–6 at 90-day follow-up. Restricted cubic splines (RCS) and logistic regression (LR) analysis were utilized to estimate the link between the CTI and clinical outcomes.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 813 patients, a high CTI level was significantly correlated with unfavorable functional outcome (<i>p</i> < 0.05). Compared with patients in the lowest quartile (Q1) of CTI, those in the highest CTI quartile (Q4) demonstrated an increased likelihood of unfavorable outcome (adjusted odds ratio [aOR] of 2.04, 95% confidence interval (95% CI) of 1.17–3.54). RCS modeling, after adjustment for significant variables identified in the univariate analysis, confirmed that there was no nonlinear connection between CTI levels and the probability of unfavorable functional recovery. Stratified analysis indicated that these associations were more significant among elderly and non-smoking patients.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The CTI is an independent indicator of functional outcomes in individuals with AIS undergoing EVT, underlining its potential clinical value as a readily accessible marker for risk stratification and individualized prognostic assessment.</p>\n </section>\n </div>","PeriodicalId":9081,"journal":{"name":"Brain and Behavior","volume":"16 10","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13624537/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain and Behavior","FirstCategoryId":"102","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/brb3.71770","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Purpose
The C-reactive protein–triglyceride–glucose index (CTI), capturing insulin resistance (IR) and systemic inflammation, is related to stroke prognosis in general, but has not yet been studied with respect to functional outcomes after endovascular thrombectomy (EVT).
Methods
A retrospective analysis was carried out on individuals with acute ischemic stroke (AIS) experiencing EVT (September 2018–December 2024). CTI is measured as: 0.412 × Ln (C-reactive protein) (mg/L) + Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)]/2. The endpoint was unfavorable functional outcomes, characterized by a modified Rankin Scale (mRS) score of 3–6 at 90-day follow-up. Restricted cubic splines (RCS) and logistic regression (LR) analysis were utilized to estimate the link between the CTI and clinical outcomes.
Results
Among 813 patients, a high CTI level was significantly correlated with unfavorable functional outcome (p < 0.05). Compared with patients in the lowest quartile (Q1) of CTI, those in the highest CTI quartile (Q4) demonstrated an increased likelihood of unfavorable outcome (adjusted odds ratio [aOR] of 2.04, 95% confidence interval (95% CI) of 1.17–3.54). RCS modeling, after adjustment for significant variables identified in the univariate analysis, confirmed that there was no nonlinear connection between CTI levels and the probability of unfavorable functional recovery. Stratified analysis indicated that these associations were more significant among elderly and non-smoking patients.
Conclusion
The CTI is an independent indicator of functional outcomes in individuals with AIS undergoing EVT, underlining its potential clinical value as a readily accessible marker for risk stratification and individualized prognostic assessment.
期刊介绍:
Brain and Behavior is supported by other journals published by Wiley, including a number of society-owned journals. The journals listed below support Brain and Behavior and participate in the Manuscript Transfer Program by referring articles of suitable quality and offering authors the option to have their paper, with any peer review reports, automatically transferred to Brain and Behavior.
* [Acta Psychiatrica Scandinavica](https://publons.com/journal/1366/acta-psychiatrica-scandinavica)
* [Addiction Biology](https://publons.com/journal/1523/addiction-biology)
* [Aggressive Behavior](https://publons.com/journal/3611/aggressive-behavior)
* [Brain Pathology](https://publons.com/journal/1787/brain-pathology)
* [Child: Care, Health and Development](https://publons.com/journal/6111/child-care-health-and-development)
* [Criminal Behaviour and Mental Health](https://publons.com/journal/3839/criminal-behaviour-and-mental-health)
* [Depression and Anxiety](https://publons.com/journal/1528/depression-and-anxiety)
* Developmental Neurobiology
* [Developmental Science](https://publons.com/journal/1069/developmental-science)
* [European Journal of Neuroscience](https://publons.com/journal/1441/european-journal-of-neuroscience)
* [Genes, Brain and Behavior](https://publons.com/journal/1635/genes-brain-and-behavior)
* [GLIA](https://publons.com/journal/1287/glia)
* [Hippocampus](https://publons.com/journal/1056/hippocampus)
* [Human Brain Mapping](https://publons.com/journal/500/human-brain-mapping)
* [Journal for the Theory of Social Behaviour](https://publons.com/journal/7330/journal-for-the-theory-of-social-behaviour)
* [Journal of Comparative Neurology](https://publons.com/journal/1306/journal-of-comparative-neurology)
* [Journal of Neuroimaging](https://publons.com/journal/6379/journal-of-neuroimaging)
* [Journal of Neuroscience Research](https://publons.com/journal/2778/journal-of-neuroscience-research)
* [Journal of Organizational Behavior](https://publons.com/journal/1123/journal-of-organizational-behavior)
* [Journal of the Peripheral Nervous System](https://publons.com/journal/3929/journal-of-the-peripheral-nervous-system)
* [Muscle & Nerve](https://publons.com/journal/4448/muscle-and-nerve)
* [Neural Pathology and Applied Neurobiology](https://publons.com/journal/2401/neuropathology-and-applied-neurobiology)